Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 71Thoracic 8Sarcoma 6CNS 6Tumor-Agnostic 3Other solid neoplasm 3Head & Neck 3Gynecologic 3Endocrine 2Breast 2NET 1Genitourinary 1

Conditions

Neoplasms 2Carcinoma, Squamous Cell 1

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 48Radiotherapy 39Magnetic Resonance Spectroscopy 35pembrolizumab 31Gemcitabine 30Bevacizumab 30Nivolumab 29Carboplatin 29Radiosurgery 27Standard of Care 26Oxaliplatin 26Capecitabine 25Paclitaxel 24Interviews as Topic 24Cisplatin 24Fluorouracil 23Erlotinib Hydrochloride 22Everolimus 19Irinotecan 18Trastuzumab 17Methods 17Exercise 17Docetaxel 17Biopsy 17Cyclophosphamide 16Educational Status 15Sorafenib 14Ipilimumab 14Fluorodeoxyglucose F18 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × irinotecan sucrosofate × Tumor-Agnostic × Clear all
NCT03719924 2025-01-08

OESIRI

Federation Francophone de Cancerologie Digestive

Phase 2 Completed
106 enrolled
Tumor-Agnostic

Carcinoma, Squamous Cell

NCT00062842 2020-03-04

Study of Irinotecan on a Weekly Schedule in Children

Baylor College of Medicine

Phase 1 Completed
23 enrolled
Tumor-Agnostic

Neoplasms

NCT02640365 2017-01-31

DOUBLIRI

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 1 Completed
10 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡